Literature DB >> 24293673

Use of lomustine (CCNU) in a case of cutaneous equine lymphoma.

Aimie J Doyle1, Valerie S MacDonald, Andrea Bourque.   

Abstract

A 12-year-old gelding was diagnosed with recurrent lymphoma in multiple cutaneous sites. A highly invasive preputial mass caused urethral obstruction. The horse was treated with surgery and chemotherapy consisting of lomustine (CCNU) and prednisolone. The treatment was well-tolerated and effective. This is the first reported use of lomustine (CCNU) in a horse for the treatment of equine lymphoma.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24293673      PMCID： PMC3831386     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  12 in total

1.  Use of lomustine to treat cutaneous nonepitheliotropic lymphoma in a cat.

Authors:  Shinobu Komori; Shinichiro Nakamura; Kimimasa Takahashi; Masahiro Tagawa
Journal:  J Am Vet Med Assoc       Date:  2005-01-15       Impact factor: 1.936

2.  Immunotherapy of equine cutaneous lymphosarcome using low dose cyclophosphamide and autologous tumor cells infected with vaccinea virus.

Authors:  R D Gollagher; B Ziola; B J Chelack; D M Haines
Journal:  Can Vet J       Date:  1993-06       Impact factor: 1.008

3.  Clinical, histopathological and immunophenotypical findings in five horses with cutaneous malignant lymphoma.

Authors:  C M de Bruijn; J N Veenman; V P M G Rutten; E Teske; R A van Nieuwstadt; T S G A M van den Ingh
Journal:  Res Vet Sci       Date:  2006-12-15       Impact factor: 2.534

4.  Two hundred three cases of equine lymphoma classified according to the World Health Organization (WHO) classification criteria.

Authors:  A C Durham; C A Pillitteri; M San Myint; V E Valli
Journal:  Vet Pathol       Date:  2012-06-13       Impact factor: 2.221

5.  Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004).

Authors:  R E Risbon; L P de Lorimier; K Skorupski; K E Burgess; P J Bergman; J Carreras; K Hahn; A Leblanc; M Turek; J Impellizeri; R Fred; J W Wojcieszyn; K Drobatz; C A Clifford
Journal:  J Vet Intern Med       Date:  2006 Nov-Dec       Impact factor: 3.333

6.  Clinical, laboratory, and histopathologic features of equine lymphoma.

Authors:  J Meyer; J Delay; D Bienzle
Journal:  Vet Pathol       Date:  2006-11       Impact factor: 2.221

7.  Poorly differentiated leiomyosarcoma of the urogenital tract in a horse.

Authors:  Samuel D A Hurcombe; Nathan M Slovis; Catherine W Kohn; Michael Oglesbee
Journal:  J Am Vet Med Assoc       Date:  2008-12-15       Impact factor: 1.936

8.  Use of chemotherapy for treatment of a mixed-cell thoracic lymphoma in a horse.

Authors:  Montague N Saulez; John W Schlipf; Christopher K Cebra; Sean P McDonough; Karyn E Bird
Journal:  J Am Vet Med Assoc       Date:  2004-03-01       Impact factor: 1.936

9.  Equine malignant lymphomas: morphologic and immunohistochemical classification.

Authors:  L C Kelley; E A Mahaffey
Journal:  Vet Pathol       Date:  1998-07       Impact factor: 2.221

10.  Immunohistochemical characterization of estrogen and progesterone receptors in lymphoma of horses.

Authors:  Kristin L. Henson; A. Rick Alleman; Lynda C. Kelley; Edward A. Mahaffey
Journal:  Vet Clin Pathol       Date:  2000       Impact factor: 1.180
View more
  1 in total

1.  Retrospective evaluation of clinical outcome after chemotherapy for lymphoma in 15 equids (1991-2017).

Authors:  Daniela Luethy; Angela E Frimberger; Daniela Bedenice; Barbara S Byrne; Erin S Groover; Rachel B Gardner; Trisha Lewis; Valerie S MacDonald; Lauren Proctor-Brown; Joy E Tomlinson; Kenneth M Rassnick; Amy L Johnson
Journal:  J Vet Intern Med       Date:  2019-01-12       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.